The latest arrival of the 40mg Tirzepatide dose represents a potentially groundbreaking advancement in the treatment of type 2 the condition . This therapy builds upon the established success of lower dosages , showing encouraging results in reducing blood glucose readings and supporting weight loss . Experts are investigating its complete effect o